PATENT CLAIM ANALYSIS

Application Number: 16044255
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["514", "391000"]

Abstract:
This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.

Claim (Index 15):
The pharmaceutical composition of  claim 14 , wherein the concentration enhancing polymer is the ionizable cellulosic polymer and the ionizable cellulosic polymer is selected from the group consisting of hydroxypropyl methyl cellulose acetate succinate, carboxymethyl ethyl cellulose, cellulose acetate phthalate, hydroxypropyl methyl cellulose phthalate, methyl cellulose acetate phthalate, cellulose acetate trimellitate, hydroxypropyl cellulose acetate phthalate, hydroxypropyl methyl cellulose acetate phthalate, cellulose acetate terephthalate, and cellulose acetate isophthalate.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13843224', '13494668', '11799447', '10459808', '13610350']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8100866792730138
- 35 USC 102 Novelty (BERT): 0.4993142117061184
- Combined Prediction Score: 0.7790094325163244
- Mean Citation Score: 260.50458
- Max Citation Score: 271.86276000000004
- Similarity Product: 232.3744611572242

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test